Literature DB >> 36147826

Bacteriophage Therapy as a Potential Management Option for Surgical Wound Infections.

L Nadareishvili1, N Hoyle1,2, N Nakaidze2, D Nizharadze1, M Kutateladze3, N Balarjishvili3, E Kutter2, N Pruidze1.   

Abstract

To investigate the potential role of bacteriophages in the treatment of surgical infections, we conducted a retrospective analysis of four surgical patients who have sought treatment at the Eliava Phage Therapy Center, Tbilisi, Georgia. Two patients had chronic osteomyelitis, one presented with a diabetic foot ulcer, and the fourth patient had developed a severe infectious complication after skin grafting surgery. Patients were treated with different combinations of bacteriophage preparations, based on the sensitivity of the isolated bacterial strain toward commercially available bacteriophages. The treatment lasted on average for 1 month, and positive results were obtained in all four cases: the wounds have healed, the general health status of the patients has improved. No allergic or adverse reactions have been observed throughout the treatment. Copyright 2020, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  Eliava; antibiotic resistance; bacteriophage; phage therapy; surgical infections; wound healing

Year:  2020        PMID: 36147826      PMCID: PMC9041461          DOI: 10.1089/phage.2020.0010

Source DB:  PubMed          Journal:  Phage (New Rochelle)        ISSN: 2641-6530


  27 in total

1.  Phage offer a real alternative.

Authors:  Gary K Schoolnik; William C Summers; James D Watson
Journal:  Nat Biotechnol       Date:  2004-05       Impact factor: 54.908

Review 2.  Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.

Authors:  Ayman El-Shibiny; Salma El-Sahhar
Journal:  Can J Microbiol       Date:  2017-09-01       Impact factor: 2.419

3.  Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.

Authors:  Anne Bruttin; Harald Brüssow
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care.

Authors:  Akhil K Seth; Matthew R Geringer; Khang T Nguyen; Sonya P Agnew; Zari Dumanian; Robert D Galiano; Kai P Leung; Thomas A Mustoe; Seok J Hong
Journal:  Plast Reconstr Surg       Date:  2013-02       Impact factor: 4.730

5.  Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms.

Authors:  Quan-Guo Zhang; Angus Buckling
Journal:  Evol Appl       Date:  2012-01-13       Impact factor: 5.183

6.  Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.

Authors:  Sanjay Chhibber; Tarsem Kaur
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 7.  Applications of Bacteriophages in the Treatment of Localized Infections in Humans.

Authors:  Vera V Morozova; Valentin V Vlassov; Nina V Tikunova
Journal:  Front Microbiol       Date:  2018-08-02       Impact factor: 5.640

8.  Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP).

Authors:  Scot E Dowd; Randall D Wolcott; Yan Sun; Trevor McKeehan; Ethan Smith; Daniel Rhoads
Journal:  PLoS One       Date:  2008-10-03       Impact factor: 3.240

9.  Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model.

Authors:  Chandan Kishor; Raghvendra Raman Mishra; Shyam K Saraf; Mohan Kumar; Arvind K Srivastav; Gopal Nath
Journal:  Indian J Med Res       Date:  2016-01       Impact factor: 2.375

10.  Resolving Digital Staphylococcal Osteomyelitis Using Bacteriophage-A Case Report.

Authors:  Randolph Fish; Elizabeth Kutter; Daniel Bryan; Gordon Wheat; Sarah Kuhl
Journal:  Antibiotics (Basel)       Date:  2018-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.